Please Wait

Applying Filters...

Octreotide
CEP/COS
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Octreotide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 27 USDMF, 8 CEP/COS, 4 JDMF, 5 EU WC, 1 KDMF, 20 NDC API, 27 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

FINISHED DOSAGE FORMULATIONS

238 FDF Dossiers, 61 FDA Orange Book, 92 Europe, 11 Canada, 48 Australia, 8 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML, INJECTABLE;INJECTION - EQ 0.1MG BASE/ML, INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.5MG BASE/ML, INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Pfanstiehl, 2 Actylis, 1 BASF, 1 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 11 Chewable & Orodispersible Aids, 10 Direct Compression, 10 Taste Masking, 7 Parenteral, 7 Disintegrants & Superdisintegrants, 5 Co-Processed Excipients, 3 Granulation, 1 Solubilizers, 1 Topical, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 38 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 79 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

17 APIs, 16 FDF Dossiers

PATENTS & EXCLUSIVITIES

24 US Patents, 1 US Exclusivities

REF. STANDARDS & IMPURITIES

2 USP, 6 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/03/2025	Bachem AG	Switzerland	Bachem AG Bubendorf CH	R0-CEP 2020-229 - Rev 01	Octreotide	2022-07-18	Valid	Chemical		2414
28/03/2025	Chengdu Shengnuo Biopharm	China	CHENGDU SHENGNUO BIOPHARM CO., LTD. Chengdu City CN	R0-CEP 2021-365 - Rev 00	Octreotide	2022-10-26	Valid	Chemical		2414

Contact us
to update this info

Octreotide

Octreotide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers

27 USDMF

8 CEP/COS

4 JDMF

5 EU WC

1 KDMF

20 NDC API

27 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

24 Drugs in Development

FINISHED DOSAGE FORMULATIONS

238 FDF Dossiers

61 FDA Orange Book

92 Europe

11 Canada

48 Australia

8 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML

INJECTABLE;INJECTION - EQ 0.1MG BASE/ML

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.5MG BASE/ML

INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

1 Faran Shimi Pharmaceutical

1 Gangwal Healthcare

1 Pfanstiehl

2 Actylis

1 BASF

1 Finar

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

2 Kerry

2 Microlex e.U

1 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

11 Chewable & Orodispersible Aids

10 Direct Compression

10 Taste Masking

7 Parenteral

7 Disintegrants & Superdisintegrants

5 Co-Processed Excipients

3 Granulation

1 Solubilizers

1 Topical

1 API Stability Enhancers

1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

38 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

79 Regulatory FDF Prices

10 Annual Reports

MARKET PLACE

17 APIs

16 FDF Dossiers

PATENTS & EXCLUSIVITIES

24 US Patents

1 US Exclusivities

REF. STANDARDS & IMPURITIES

2 USP

6 Others

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons